ArticleOncoTargets and therapy2018

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells.

Ya-Lan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.